サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1540845

抗凝固剤市場レポート：薬剤クラス別、投与経路別、流通チャネル別、用途別、地域別、2024～2032年

Anticoagulants Market Report by Drug Class, Route of Administration, Distribution Channel, Application, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 143 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
抗凝固剤市場レポート：薬剤クラス別、投与経路別、流通チャネル別、用途別、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗凝固剤市場規模は2023年に412億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに909億米ドルに達し、2024～2032年の間に8.9％の成長率（CAGR）を示すと予測しています。血栓性疾患患者の増加、座りがちなライフスタイル、医療セグメントの改善が市場を牽引する主要要因のひとつです。

抗凝固剤は、血栓の形成を防ぎ、脳卒中や心臓発作などの重篤な症状を発症する可能性を低減する医薬品です。血管を通る血液の流れに抵抗する既存の血栓の治療を補助し、血栓が大きくなるのを防いで重篤な合併症のリスクを軽減します。抗凝固剤には、錠剤やカプセルなどの経口剤と注射剤があり、強さや色もさまざまです。現在、直接経口抗凝固剤（DOAc）は、その使いやすさと定期的なモニタリングの必要性のなさから、ますます処方されるようになってきています。

抗凝固剤市場傾向：

高齢者人口の増加、ヒト免疫不全ウイルス（HIV）、ライム病、肥満、C型肝炎、慢性炎症、心血管障害の世界の有病率の増加は、全世界の市場にプラスの影響を与えている主要因の1つです。また、座りっぱなしのライフスタイルや多忙な勤務スケジュールにより、肺塞栓症（PE）などの血栓性疾患の症例が増加していることが、世界の心臓関連疾患の成長を促しています。さらに、長時間の座位、喫煙、外傷、血液疾患、自己免疫疾患は、身体のさまざまな部位で血液凝固のリスクを増大させており、これが抗凝固剤の需要を刺激しています。これとは別に、創薬における研究開発（R&D）活動の新興国市場の進展や、大量のデータを分析して潜在的な薬剤候補を特定し、新薬を開発するための人工知能（AI）や機械学習（ML）などの先端技術の統合が、市場開拓に拍車をかけています。これに伴い、医療プロバイダーは、遺伝子データや臨床データに基づいて個々の患者の抗凝固療法を個別化することに注力しています。AIは、患者にとって最も効果的な抗凝固剤の投与量と種類を特定するのに役立ち、ひいては合併症のリスクを低減して転帰を改善します。さらに、心臓血管の健康に関する認識を促進するための非営利団体による好意的な取り組みや、心臓病や脳卒中を予防するための各国政府と公衆衛生機関とのパートナーシップの拡大が、世界市場の成長を後押ししています。医療部門の急成長や、医薬品の価格や入手しやすさの向上といったその他の要因も、市場の成長を刺激しています。

本レポートで扱う主要質問

  • 2023年の世界の抗凝固剤市場の市場規模は？
  • 2024～2032年の世界の抗凝固剤市場の予想成長率は？
  • 世界の抗凝固剤市場を牽引する主要因は何か？
  • 世界の抗凝固剤市場に対するCOVID-19の影響は？
  • 抗凝固剤市場の薬剤クラス別内訳は？
  • 世界の抗凝固剤市場の投与経路別の内訳は？
  • 世界の抗凝固剤市場の流通チャネル別の内訳は？
  • 世界の抗凝固剤市場の用途別内訳は？
  • 世界の抗凝固剤市場における主要地域は？
  • 世界の抗凝固剤市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の抗凝固剤市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：薬剤クラス別

  • 新規経口抗凝固剤（NOAC）
  • ヘパリンと低分子量ヘパリン（LMWH）
  • ビタミンK拮抗薬
  • その他

第7章 市場内訳：投与経路別

  • 経口抗凝固剤
  • 注射抗凝固剤

第8章 市場内訳：流通チャネル別

  • 病院薬局
  • 小売薬局
  • オンラインストア
  • その他

第9章 市場内訳：用途別

  • 心房細動と心臓発作
  • 脳卒中
  • 深部静脈血栓症（DVT）
  • 肺塞栓症（PE）
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Alexion Pharmaceuticals Inc
    • Aspen Holdings
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • Daiichi Sankyo Company Limited
    • Dr. Reddy's Laboratories Ltd
    • GlaxoSmithKline plc
    • Johnson & Johnson Private Limited
    • Pfizer Inc.
    • Sanofi
図表

List of Figures

  • Figure 1: Global: Anticoagulants Market: Major Drivers and Challenges
  • Figure 2: Global: Anticoagulants Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Anticoagulants Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Anticoagulants Market: Breakup by Drug Class (in %), 2023
  • Figure 5: Global: Anticoagulants Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Anticoagulants Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Anticoagulants Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Anticoagulants Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Anticoagulants (Vitamin K Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Anticoagulants (Vitamin K Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Anticoagulants (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Anticoagulants (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Anticoagulants (Oral Anticoagulant) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Anticoagulants (Oral Anticoagulant) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Anticoagulants (Injectable Anticoagulant) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Anticoagulants (Injectable Anticoagulant) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Anticoagulants (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Anticoagulants (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Anticoagulants (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Anticoagulants (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Anticoagulants (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Anticoagulants (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Anticoagulants (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Anticoagulants (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Anticoagulants (Stroke) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Anticoagulants (Stroke) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Anticoagulants (Pulmonary Embolism-PE) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Anticoagulants (Pulmonary Embolism-PE) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Anticoagulants (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Anticoagulants (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: Anticoagulants Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: Anticoagulants Industry: SWOT Analysis
  • Figure 89: Global: Anticoagulants Industry: Value Chain Analysis
  • Figure 90: Global: Anticoagulants Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anticoagulants Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Anticoagulants Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 3: Global: Anticoagulants Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 4: Global: Anticoagulants Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Anticoagulants Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Anticoagulants Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Anticoagulants Market: Competitive Structure
  • Table 8: Global: Anticoagulants Market: Key Players
目次
Product Code: SR112024A4360

The global anticoagulants market size reached US$ 41.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 90.9 Billion by 2032, exhibiting a growth rate (CAGR) of 8.9% during 2024-2032. The rising cases of thrombotic disorders, sedentary lifestyles, and the improving healthcare sector represent some of the key factors driving the market.

Anticoagulants are medicines that prevent the formation of blood clots and reduce the chances of developing severe conditions, such as strokes and heart attacks. They assist in treating existing blood clots that resist the flow of blood through vessels and prevent them from getting larger and reducing the risk of serious complications. They are available in different strengths and colors and as oral, such as tablets and capsules, and injectable variants. At present, direct oral anticoagulants (DOAc) are increasingly being prescribed on account of their ease of use and lack of need for routine monitoring.

Anticoagulants Market Trends:

The growing geriatric population and increasing prevalence of human immunodeficiency virus (HIV), lyme disease, obesity, hepatitis C, chronic inflammation, and cardiovascular disorders across the globe represent one of the key factors positively influencing the market across the globe. In addition, rising cases of thrombotic disorders, such as pulmonary embolism (PE), on account of sedentary lifestyles and hectic work schedules are inducing the growth of heart-related diseases worldwide. Moreover, extended sitting, smoking, trauma, blood disorders, and autoimmune diseases are increasing the risk of blood clotting in different parts of the body, which, in turn, is catalyzing the demand for anticoagulants. Apart from this, increasing advancements in research and development (R&D) activities in drug discovery and the integration of advanced technologies, such as artificial intelligence (AI) and machine learning (ML) to analyze large amounts of data, identify potential drug candidates and develop a new drug is fueling the market growth. In line with this, healthcare providers are focusing on personalizing anticoagulant therapy for individual patients based on their genetic and clinical data. AI assists in identifying the most effective dose and type of anticoagulant for the patient, which, in turn, reduces the risk of complications and improves outcomes. Furthermore, favorable initiatives by non-profitable organizations to promote awareness about cardiovascular health and the growing partnerships between governments of various countries and public health agencies to prevent heart disease and strokes are propelling the growth of the market worldwide. Other factors like the burgeoning healthcare sector and increasing affordability and accessibility of drugs are stimulating the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global anticoagulants market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class, route of administration, distribution channel and application.

Drug Class Insights:

Novel Oral Anticoagulants (NOACs)

Heparin and Low Molecular Weight Heparin (LMWH)

Vitamin K Antagonist

Others

The report has provided a detailed breakup and analysis of the anticoagulants market based on the drug class. This includes novel oral anticoagulants (NOACs), heparin and low molecular weight heparin (LMWH), vitamin K antagonist, and others. According to the report, novel oral anticoagulants (NOACs) represented the largest segment.

Route of Administration Insights:

Oral Anticoagulant

Injectable Anticoagulant

A detailed breakup and analysis of the anticoagulants market based on the route of administration has also been provided in the report. This includes oral anticoagulant and injectable anticoagulant. According to the report, oral anticoagulant accounted for the largest market share.

Distribution Channel Insights:

Hospital Pharmacies

Retail Pharmacies

Online Stores

Others

A detailed breakup and analysis of the anticoagulants market based on the distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, online stores, and others. According to the report, hospital pharmacies accounted for the largest market share.

Application Insights:

Atrial Fibrillation and Heart Attack

Stroke

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Others

A detailed breakup and analysis of the anticoagulants market based on the application has also been provided in the report. This includes atrial fibrillation and heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and others. According to the report, atrial fibrillation and heart attack accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for anticoagulants. Some of the factors driving the North America anticoagulants market included the increasing prevalence of thrombotic disorders, developed healthcare sector, ongoing research and development (R&D) activities in drug discovery etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global anticoagulants market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Alexion Pharmaceuticals Inc, Aspen Holdings, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc., Sanofi, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global anticoagulants market in 2023?
  • 2. What is the expected growth rate of the global anticoagulants market during 2024-2032?
  • 3. What are the key factors driving the global anticoagulants market?
  • 4. What has been the impact of COVID-19 on the global anticoagulants market?
  • 5. What is the breakup of the global anticoagulants market based on the drug class?
  • 6. What is the breakup of the global anticoagulants market based on the route of administration?
  • 7. What is the breakup of the global anticoagulants market based on the distribution channel?
  • 8. What is the breakup of the global anticoagulants market based on the application?
  • 9. What are the key regions in the global anticoagulants market?
  • 10. Who are the key players/companies in the global anticoagulants market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anticoagulants Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Novel Oral Anticoagulants (NOACs)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Heparin and Low Molecular Weight Heparin (LMWH)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Vitamin K Antagonist
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral Anticoagulant
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Injectable Anticoagulant
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Atrial Fibrillation and Heart Attack
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Stroke
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Deep Vein Thrombosis (DVT)
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Pulmonary Embolism (PE)
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Alexion Pharmaceuticals Inc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Aspen Holdings
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Boehringer Ingelheim International GmbH
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Bristol-Myers Squibb Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Daiichi Sankyo Company Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Dr. Reddy's Laboratories Ltd
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 GlaxoSmithKline plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Johnson & Johnson Private Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sanofi
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis